Meta-analysisindependent cross-checkfull text checked I-FRU-03 in-depth review

Fruits, vegetables and diabetes

Fruit and vegetable consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of prospective studies.

Overview

Halvorsen RE et al.. BMJ Nutr Prev Health 2021 · PMID 35028521 · DOI 10.1136/bmjnph-2020-000218

Eating more fruit was linked to about 7% lower diabetes risk. Grapes/raisins and apples looked favourable; cantaloupe and sweetened fruit drinks were linked to higher risk, but in very few studies. 100% fruit juice showed no clear link.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

F&V and diabetes

How was the study done?

Meta-analysis

How many people, animals or samples were studied?

23 cohorts

What was actually found?

Weak inverse

How large was the observed effect?

RR 0.93

What do the results mean in everyday life?

Whole fruit good

What are the study's limitations?

Few studies per fruit type, mostly the same US cohorts; no registered protocol; observational

What does it say about Elawady's specific claim?

Mixed: weak, few-study signal for cantaloupe; favourable for grapes; sweetened fruit drinks (nectars) linked to higher risk

Do the results apply to Germany and Europe?

Moderate

What can explicitly not be concluded from this study?

Cause

Scientific in-depth review

1. Full reference

Authors
Halvorsen RE et al.
Journal
BMJ Nutr Prev Health
Year
2021
Identifier
PMID 35028521 DOI 10.1136/bmjnph-2020-000218
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
full text
Conflicts of interest and funding

No specific grant from any funding agency; authors declare no competing interests (full text).

2. Research question

Fruit/vegetable subtypes and T2D

3. Study design and population

Study design
Meta-analysis – Systematic review and dose-response meta-analysis
Population

Adults free of T2D at baseline in 23 prospective cohort, case-cohort or nested case-control studies (42 publications): 10 from America, 5 Europe, 5 Asia, 3 Australia; follow-up 4-30 years

Country

Multiple (10 American, 5 European, 5 Asian, 3 Australian studies)

Period

PubMed and Embase searched to 20 October 2020

Sample size

23 cohort studies (42 publications); fruit analysis 20 studies, 81,313 cases, 1,542,306 participants; fruit and vegetables combined 10 studies, 29,768 cases, 729,478 participants; subtype analyses mostly 2-6 studies

Inclusion and exclusion criteria

Prospective cohort, case-cohort or nested case-control studies of fruit/vegetables, subtypes, fruit juices or fruit drinks and T2D; free of T2D at baseline; multivariable-adjusted RRs with CIs; for dose-response, intake levels, cases and person-years. Most-cases publication used for duplicate cohorts; no language restriction; excluded studies listed in supplementary table 2.

4. Methods and endpoints

Exposure / intervention

Fruit and vegetables combined, total fruit, total vegetables and subtypes (incl. apples, grapes/raisins, bananas, cantaloupe, watermelon, citrus), fruit juice, 100% fruit juice, fruit drinks, potatoes

Comparator

Lowest vs highest intake category; per 200 g/day (totals), per 100 g/day or 50 g/day (subtypes), per 250 g/day (juices/drinks)

Endpoints

T2D

Statistical methods

DerSimonian-Laird random effects; Greenland-Longnecker linear dose-response; restricted cubic splines for non-linearity; I2; subgroup/meta-regression for exposures with >=8 studies; Egger test (P<=0.1) and funnel plots; leave-one-out influence analyses; modified Newcastle-Ottawa Scale (0-8); WCRF evidence grading. No registered protocol.

5. Actual results

Results

High vs low: fruit and vegetables RR 0.93 (0.89 to 0.98, I2 0%, n=10); fruit 0.93 (0.90 to 0.97, I2 9.3%, n=20); vegetables 0.95 (0.88 to 1.02). Per 200 g/day: F&V 0.98 (0.95 to 1.01); fruit 0.96 (0.92 to 1.00, I2 68.4%); vegetables 0.97 (0.94 to 1.01). Non-linear: 8-12% lower risk at 100-500 g/day fruit. Subtypes (dose-response): apples 0.91 (0.88 to 0.95)/100 g; grapes and raisins 0.74 (0.66 to 0.83)/50 g; blueberries 0.60 (0.49 to 0.73)/50 g; grapefruit 0.90 (0.82 to 0.99)/100 g; cantaloupe 1.18 (1.04 to 1.34)/100 g; watermelon 1.05 (1.00 to 1.11)/100 g (2 studies); bananas 0.93 (0.80 to 1.08); fruit drinks 1.13 (1.01 to 1.27)/250 g; fruit juice 1.08 (1.00 to 1.16)/250 g (I2 68.7%); 100% fruit juice 0.97 (0.91 to 1.03)/250 g (4 studies); potatoes total 1.08 (1.02 to 1.15)/100 g. WCRF grading: fruit 'probable' inverse; F&V limited-suggestive; vegetables limited-no conclusion; all subtypes limited-suggestive or limited-no conclusion.

Absolute risks

not reported in full text

Authors' conclusion

Weak inverse association of fruit and vegetable intake with T2D; supports recommendations to increase fruit intake; some subtypes (apples, blueberries, grapefruit, grapes and raisins) may be particularly beneficial while potatoes and fruit juice may increase risk; subtype findings rest on few studies and possible selective reporting and need confirmation.

6. Strengths

  • Two databases, no language restriction, duplicate screening and quality assessment, excluded studies listed
  • Large number of cohorts and participants for total fruit
  • High vs low, linear and non-linear dose-response, subgroup, influence and publication-bias analyses
  • Transparent WCRF evidence grading per exposure

7. Weaknesses

  • No registered protocol (stated by authors)
  • Subtype analyses based on 2-6 studies, many from the same US cohorts (NHS, NHS II, HPFS); possible selective reporting
  • Observational: residual confounding, few studies adjusted for other dietary factors; FFQ measurement error; mostly baseline-only diet
  • Fruit result attenuated/absent in studies adjusting for waist circumference
  • Several results sensitive to single studies (fruit dose-response, fruit drinks, potatoes)
  • Funding of included studies not reported; overlap with other fruit meta-analyses (e.g. I-FRU-01) means not independent confirmation
  • No Middle Eastern cohorts; dates, figs and mango not analysed

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
structured assessment based on the full text by a single reviewer (no formal double review)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Strict AMSTAR 2: low confidence (one critical flaw: no protocol). Overall bias unchanged. Subtype results (cantaloupe, watermelon, grapes) rest on very few, overlapping US cohorts and are graded limited by the authors. Simplified single-reviewer judgement from the full text; formal AMSTAR 2/ROBIS requires two independent reviewers.

8. Risk of bias
DomainJudgementRationale
Item 1 PICOlowExposures, outcome and designs defined.
Item 2 (critical) protocolhighAuthors state there was no registered protocol.
Item 3 design selectionlowProspective designs only, rationale given (recall/selection bias).
Item 4 (critical) comprehensive searchsome concernsPubMed and Embase without filters, reference lists, no language restriction; no grey literature (partial yes).
Items 5-6 duplicate selection and extractionlowScreening and selection in duplicate; extraction by one author double-checked by a second.
Item 7 (critical) excluded studieslowExcluded studies listed in supplementary table 2.
Item 8 description of included studieslowSupplementary table 4 describes study characteristics.
Item 9 (critical) RoB of individual studiessome concernsModified Newcastle-Ottawa Scale in duplicate; not a domain-based RoB tool for confounding (partial yes).
Item 10 funding of included studieshighNot reported.
Item 11 (critical) meta-analytic methodslowRandom effects, appropriate dose-response and spline methods; assumptions for open categories stated.
Item 12 impact of RoBlowSubgroup by study quality and by confounder adjustment.
Item 13 (critical) RoB in interpretationlowAuthors caution about few studies, selective reporting and confounding; WCRF grading.
Item 14 heterogeneitylowExplored by subgroup and meta-regression.
Item 15 (critical) publication biaslowEgger tests and funnel plots for >=8 studies; sensitivity analyses for outliers; subtype analyses too small to test.
Item 16 review COIlowNo funding, no competing interests declared.

Full-text review (25 October 2026): Added dose-response and subtype estimates incl. watermelon 1.05 (1.00-1.11), grapes/raisins 0.74, 100% fruit juice null 0.97 (0.91-1.03) versus fruit drinks 1.13, WCRF grading (subtypes only limited evidence), no registered protocol, no funding. Bias overall unchanged (some_concerns; AMSTAR 2 low confidence) with itemised domains.

9. Assessment of the statistical interpretation

Small relative risk reductions for total fruit (7% high vs low); linear dose-response for fruit borderline (0.96, 0.92-1.00) with high heterogeneity. Subtype estimates are imprecise and based on few studies. Mixed 'fruit juice' category is borderline (1.08, 1.00-1.16), whereas 100% fruit juice alone is null (0.97, 0.91-1.03) and sweetened fruit drinks positive (1.13, 1.01-1.27).

10. Relevance to the specific claim

Context for C-FRU-01/03/05.

11. Independent contrary findings

12. Transferability to Germany and Europe

Moderate.

13. Overall methodological judgement

Reasonably conducted dose-response meta-analysis. Probable small inverse association of whole fruit with T2D; subtype signals (positive for cantaloupe and fruit drinks, inverse for grapes/raisins and apples) are hypothesis-generating only.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Data for dates, figs, mango and melons in Middle Eastern populations; whether 100% juice differs from sweetened nectars; mediation by adiposity.

15. Linked fact checks